Rethinking bio-regeneration with Dual Core Technology: Neauvia’s STIMULATE

Neauvia, a global pioneer in medical aesthetics, proudly announces that STIMULATE, featuring Dual Core Technology, has been awarded the prestigious Catalyst Award for “Most Disruptive Innovation” at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco.

The AMWC Awards are internationally renowned for celebrating scientific innovation and excellence within the global medical aesthetics market. The winners were selected by the Program Chairmen according to 6 strict selection criteria (Science, Clinical Evidence, Safety, Innovation, Applicability and Business Potential).

This 2026 recognition acknowledges STIMULATE as a true industry game-changer, building upon its previous AMWC 2024 win for “Best Injectable Dermal Filler.” The consecutive accolades highlight the product’s sustained international recognition and Neauvia’s long-term commitment to redefining expectations in regenerative treatments.

Dual Core Technology: a new approach to regeneration

At the core of this award-winning formulation is Dual Core Technology, Neauvia’s unique scientific concept that combines PEGDE-crosslinked Hyaluronic Acid (PEGDE-HA) and Calcium Hydroxyapatite (CaHA).

Developed as a single, sterile, ready-to-use product, ensuring convenience, safety, and a predictable treatment workflow for practitioners, this formula is designed to deliver comprehensive dual support: an immediate mechanical lifting effect paired with progressive observable result over time.

By combining these two complementary components, Dual Core Technology represents a new chapter in medical aesthetics, moving beyond traditional volume correction toward true tissue regeneration¹.

Furthermore, STIMULATE is the only PEG-HA and CaHA hydrogel, enriched with the amino acids Glycine and L-Proline, currently available on the market².

Expert insight

"This AMWC recognition, coupled with our latest clinical data on the Dual Core Technology, confirms that Neauvia is moving beyond simple volumization toward true tissue restoration." said Valentina Spada, Chief Scientific Officer at Neauvia.

“Stimulate allows practitioners to address the skin’s aging process at its source, delivering a synergistic action that provides an immediate structural lift while supporting long-term tissue health.”

Shaping the future of aesthetic medicine

This distinction reinforces Neauvia's vision to shape the future of medical aesthetics, transforming bio-regenerative treatments into premium experiences that integrate seamlessly into a modern, healthy lifestyle.